INVITE-ONLY SCRIPT
The Love B♥t
Updated
Private invite only script - currently "LIVE TESTING".
Back test results look great. Doesn't repaint. A lot of people might be saying, why use H.A. and all that and its not reliable etc.
The current testing you see of NEO is using 1% commission rate to account for the price difference and also the usual 0.25% commission rate.
Also, sometimes with H.A., you will buy lower than listed price or buy higher than listed price. However, with the testing I have done, it averages out.
I recommend using anywhere between 1-4 hour charts.
The strategy is using a combination of few different indicators along with moving averages.
Back test results look great. Doesn't repaint. A lot of people might be saying, why use H.A. and all that and its not reliable etc.
The current testing you see of NEO is using 1% commission rate to account for the price difference and also the usual 0.25% commission rate.
Also, sometimes with H.A., you will buy lower than listed price or buy higher than listed price. However, with the testing I have done, it averages out.
I recommend using anywhere between 1-4 hour charts.
The strategy is using a combination of few different indicators along with moving averages.
Release Notes
Updated to overlay price action.Release Notes
Optimized to work with Regular Candles.Stats based on 0.25% Commission.
Back test from January 1, 2017.
Invite-only script
Access to this script is restricted to users authorized by the author and usually requires payment. You can add it to your favorites, but you will only be able to use it after requesting permission and obtaining it from its author. Contact kokopuffs for more information, or follow the author's instructions below.
TradingView does not suggest paying for a script and using it unless you 100% trust its author and understand how the script works. In many cases, you can find a good open-source alternative for free in our Community Scripts.
Want to use this script on a chart?
Warning: please read before requesting access.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.